It is a pharma private limited company based in Latur, Maharashtra, India, established in 2013.
2013 | Latur, Maharashtra, India | ActiveGravel Pharma Private Limited, a active private limited company, was established on 14 June 2013 in Latur, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999MH2013PTC244491. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.97 M.
It upholds a compliant status. Its leadership includes Vishnudas Dwarkadas Bahndari (Director), Uttam Dagdurao Deshmane (Director), Sanjay Tukaram Jogdanad (Director). Past directors included Eknath Uttamrao Kalkote, Dhanraj Dajisaheb Shitole, Shivanand Mahadeo Dadge. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Bhakti Nagar, Latur Tq. Dist. Latur, Latur, Maharashtra, 413512.
U74999MH2013PTC244491
244491
14 June 2013
₹2.50 M
₹0.97 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Gravel Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishnudas Dwarkadas Bahndari | Director | 14 Jun 2013 | Current |
| Uttam Dagdurao Deshmane | Director | 14 Jun 2013 | Current |
| Sanjay Tukaram Jogdanad | Director | 14 Jun 2013 | Current |
| Rahul Nandkishor Laturiya | Director | 14 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Oct 2022 | Past |
| Pramod Abcsdd | Director | 05 Jul 2023 | Past |
| Pramod Abcsdd | Director | 23 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gravel Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.45% increase. The company also saw a slight improvement in profitability, with a 1.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gravel Pharma had a public holding of 81.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gravel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gravel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gravel Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gravel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Gravel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Vishnudas Dwarkadas Bahndari was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
Uttam Dagdurao Deshmane was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
Sanjay Tukaram Jogdanad was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
Rahul Nandkishor Laturiya was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
The CIN of Gravel Pharma Private Limited is U74999MH2013PTC244491.
Gravel Pharma Private Limited is headquartered at Bhakti Nagar, Latur Tq. Dist. Latur, Latur, Maharashtra, 413512.
Gravel Pharma Private Limited was incorporated on 14 June 2013.
The current directors of Gravel Pharma Private Limited are
The primary industry of Gravel Pharma Private Limited is Trade.
Gravel Pharma Private Limited is unlisted.
The authorized capital of Gravel Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹0.97 M.
The compliance status of Gravel Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX